Clinical trial
Gene Expression Profiling in PBMCs as a Tool for Prediction of Infliximab…
NCT00213564 · University Hospital, Rouen, Other · Completed
Key facts
| NCT number | NCT00213564 |
|---|---|
| Title | Gene Expression Profiling in PBMCs as a Tool for Prediction of Infliximab Responsiveness in Rheumatoid Arthritis |
| Official title | Gene Expression Profiling in PBMCs as a Tool for Prediction of Infliximab Responsiveness in Rheumatoid Arthritis |
| Lead sponsor | University Hospital, Rouen, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | response to infliximab associated with methotrexate |
| Enrollment | 40 |
| Start date | Apr 1, 2003 |
| Primary completion | May 1, 2004 |
| Completion | Dec 1, 2005 |
| First posted | Sep 21, 2005 |
| Last update posted | Jun 26, 2013 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: